Even for those using the medication solely for weight management, a drastic reduction in caloric intake combined with the medications effects can sometimes result in crashes that cause lightheadedness
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD practice guidance
It can also help improve overall health by reducing the risk of cardiovascular disease, improving blood sugar control, and increasing energy Trusted Source Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes Di Folco U, Vallecorsa N, Nardone MR, Pantano AL, Tubili C Go to Source levels
Ozempic is not currently FDA-approved for weight loss, whereas Wegovy is approved for weigh loss
Injectable therapy bypasses gastrointestinal variability, while oral agents depend heavily on precise timing and administration technique
Metabolic adaptation and the transition period Your metabolism does not flip a switch from burning primarily glucose to efficiently burning stored fat